Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study

Patrick A. Ott; Yung Jue Bang; Dominique Berton-Rigaud; Elena Elez; Michael J. Pishvaian; Hope S. Rugo; Igor Puzanov; Janice M. Mehnert; Kyaw L. Aung; Juanita Lopez; Marion Carrigan; Sanatan Saraf; Mei Chen; Jean Charles Soria

doi:10.1097/01.ogx.0000527579.58363.20

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study

Patrick A. Ott
, Yung Jue Bang
, Dominique Berton-Rigaud
, Elena Elez
, Michael J. Pishvaian
, Hope S. Rugo
, Igor Puzanov
, Janice M. Mehnert
, Kyaw L. Aung
, Juanita Lopez
, Marion Carrigan
, Sanatan Saraf
, Mei Chen
, Jean Charles Soria

Medicine

Dana-Farber Cancer Institute
Seoul National University
Centre Georges-François Leclerc
Vall d'Hebron Institute of Oncology
Georgetown University
University of California at San Francisco
Rutgers - The State University of New Jersey, New Brunswick
University Health Network
The Institute of Cancer Research
Merck
Université Paris-Saclay

Research output: Contribution to journal › Comment/debate

12 Scopus citations

Original language	English
Pages (from-to)	26-27
Number of pages	2
Journal	Obstetrical and Gynecological Survey
Volume	73
Issue number	1
DOIs	https://doi.org/10.1097/01.ogx.0000527579.58363.20
State	Published - Jan 1 2018

Access to Document

10.1097/01.ogx.0000527579.58363.20

Cite this

Ott, P. A., Bang, Y. J., Berton-Rigaud, D., Elez, E., Pishvaian, M. J., Rugo, H. S., Puzanov, I., Mehnert, J. M., Aung, K. L., Lopez, J., Carrigan, M., Saraf, S., Chen, M., & Soria, J. C. (2018). Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study. Obstetrical and Gynecological Survey, 73(1), 26-27. https://doi.org/10.1097/01.ogx.0000527579.58363.20

@article{e1b350939a08488fb070ac6fb4280f32,

title = "Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study",

author = "Ott, \{Patrick A.\} and Bang, \{Yung Jue\} and Dominique Berton-Rigaud and Elena Elez and Pishvaian, \{Michael J.\} and Rugo, \{Hope S.\} and Igor Puzanov and Mehnert, \{Janice M.\} and Aung, \{Kyaw L.\} and Juanita Lopez and Marion Carrigan and Sanatan Saraf and Mei Chen and Soria, \{Jean Charles\}",

year = "2018",

month = jan,

day = "1",

doi = "10.1097/01.ogx.0000527579.58363.20",

language = "English",

volume = "73",

pages = "26--27",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

Ott, PA, Bang, YJ, Berton-Rigaud, D, Elez, E, Pishvaian, MJ, Rugo, HS, Puzanov, I, Mehnert, JM, Aung, KL, Lopez, J, Carrigan, M, Saraf, S, Chen, M & Soria, JC 2018, 'Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study', Obstetrical and Gynecological Survey, vol. 73, no. 1, pp. 26-27. https://doi.org/10.1097/01.ogx.0000527579.58363.20

TY - JOUR

T1 - Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer

T2 - Results from the KEYNOTE-028 Study

AU - Ott, Patrick A.

AU - Bang, Yung Jue

AU - Berton-Rigaud, Dominique

AU - Elez, Elena

AU - Pishvaian, Michael J.

AU - Rugo, Hope S.

AU - Puzanov, Igor

AU - Mehnert, Janice M.

AU - Aung, Kyaw L.

AU - Lopez, Juanita

AU - Carrigan, Marion

AU - Saraf, Sanatan

AU - Chen, Mei

AU - Soria, Jean Charles

PY - 2018/1/1

Y1 - 2018/1/1

UR - https://www.scopus.com/pages/publications/85041111851

U2 - 10.1097/01.ogx.0000527579.58363.20

DO - 10.1097/01.ogx.0000527579.58363.20

M3 - Comment/debate

AN - SCOPUS:85041111851

SN - 0029-7828

VL - 73

SP - 26

EP - 27

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 1

ER -

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study

Access to Document

Other files and links

Fingerprint

Cite this